Shannon Wiley focuses her practice on healthcare regulatory and transactional matters with a specific emphasis on the pharmaceutical industry specializing in specialty pharmacy, digital pharmacy and infusion providers. Shannon provides clients with legal guidance driven by a deep understanding of their business. She assists clients with transactional and regulatory matters involving ambulatory infusion centers, management relationships for health system pharmacies and infusion practices, home infusion, specialty pharmacy, digital pharmacy, limited distribution networks, pharmacy services agreements, the 340B program and associated contract pharmacy relationships, hub arrangements, data services arrangements, and GPO agreements. She also provides guidance on matters related to billing by such providers, such as advice Medicare Part B and Part D regulations. She advises clients on regulations such as the Anti-Kickback Statute, the Health Insurance Portability and Accountability Act (HIPAA), the Civil Monetary Penalty Law, corporate practice of medicine laws, pharmacy laws, FDA regulations such as the Drug Supply Chain Security Act and state laws related to the operations of pharmacies and infusion providers.
Shannon Wiley
Member
Memphis
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Shannon Wiley
Member
Memphis
swiley@bassberry.com
https://www.bassberry.com/professionals/wiley-shannon/
Memberships
American Health Law Association (AHLA)
National Association of Specialty Pharmacies (NASP)
American Pharmacists Association (APhA)
National Infusion Center Association (NICA)
Shannon Wiley focuses her practice on healthcare regulatory and transactional matters with a specific emphasis on the pharmaceutical industry specializing in specialty pharmacy, digital pharmacy and infusion providers. Shannon provides clients with legal guidance driven by a deep understanding of their business. She assists clients with transactional and regulatory matters involving ambulatory infusion centers, management relationships for health system pharmacies and infusion practices, home infusion, specialty pharmacy, digital pharmacy, limited distribution networks, pharmacy services agreements, the 340B program and associated contract pharmacy relationships, hub arrangements, data services arrangements, and GPO agreements. She also provides guidance on matters related to billing by such providers, such as advice Medicare Part B and Part D regulations. She advises clients on regulations such as the Anti-Kickback Statute, the Health Insurance Portability and Accountability Act (HIPAA), the Civil Monetary Penalty Law, corporate practice of medicine laws, pharmacy laws, FDA regulations such as the Drug Supply Chain Security Act and state laws related to the operations of pharmacies and infusion providers.
Memberships
American Health Law Association (AHLA)
National Association of Specialty Pharmacies (NASP)
American Pharmacists Association (APhA)
National Infusion Center Association (NICA)
Representative Experience
-
Representation of AdvancedRx, a vertically integrated pharmacy services platform, in its acquisition of Automated Healthcare Solutions, a portfolio company of ABRY Partners and an in office dispensing developed proprietary billing and collections software. Terms of the transaction were not disclosed.
-
We served as regulatory counsel to Paragon healthcare, Inc., a leading provider of infusion services to patients, in its sale...
-
We represented Havencrest Capital Management, a Dallas-based, private equity fund manager specializing in the healthcare industry, in its acquisition of Tekton, a clinical trial site network with 23 sites across Texas, Colorado, Georgia, Kansas, and Oklahoma. Terms of the transaction were not disclosed.
-
Regulatory support to AdhereRx Incorporated, a pharmacy company committed to long-term pharmacy support for high-risk patients, in its sale of certain assets to Exact Care Pharmacy, a national medication management and pharmacy care provider. Terms of the transaction were not disclosed.
-
Regulatory support to AdhereRx Incorporated, a pharmacy company committed to long-term pharmacy support for high-risk patients, in its sale of certain pharmacy assets to Curexa – West, LLC, a leading provider of compounding, packaging, labeling, and digital and traditional pharmacy solutions for telemedicine and medical providers, veterinarians, manufacturers, and clinical research organizations across the nation. Terms of the transaction were not disclosed.
-
We represented Infusion Center of Pennsylvania, the largest non-hospital infusion provider in the greater Philadelphia region, in its sale to...
-
Representation of Prairie Capital’s portfolio company Family Allergy & Asthma, an allergy medical practice headquartered in Louisville, KY, in its Physician Practice Management transaction with Asthma and Allergy Associates of Florida, an allergy and asthma medical practice in Flordia. Terms of the transaction were not disclosed.
-
We represented Prairie Capital's portfolio company Family Allergy & Asthma, an allergy medical practice headquartered in Louisville, KY, in its...
-
We represented PANTHERx, a specialty pharmacy specializing in orphan drugs and rare diseases, in its sale to a consortium of...
-
Representation of ModivCare (Nasdaq: MODV), a technology-enabled healthcare services company, in its acquisition of Guardian Medical Monitoring, LLC, a remote patient monitoring and alert company, from its parent company, Guardian Alarm. Terms of the transaction were not disclosed.
Representative Experience
-
Client Type:
-
Client Type: Private Company
-
Client Type:
-
Client Type:
-
Client Type:
-
Client Type:
-
Client Type:
-
Client Type:
-
Client Type: Private Company
-
Client Type:
-
Client Type:
-
Client Type:
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type:
-
Client Type:
-
Client Type:
-
Client Type:
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
TT Capital Partners, NovaQuest Capital Management, and Frist Cressey Ventures Invests in InformedDNAClient Type: Private Company
-
Client Type: Public Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Public Company
-
Client Type: Private Company
-
Client Type: Public Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type:
-
Client Type: Private Company
-
Client Type:
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Public Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Private Company
-
Client Type: Public Company
-
Client Type: Public Company
Publications
-
December 10, 2024 | Firm Publication
-
August 8, 2024 | Firm Publication
-
July 15, 2024 | Firm Publication
Upcoming Events
-
January 13-15, 2025 | San Francisco, CaliforniaJ.P. Morgan
Past Events
-
September 12-13, 2024 | Nashville, TennesseeBass, Berry & Sims
-
April 28-May 2, 2024 | Las Vegas, NevadaAsembia Specialty Pharmacy Summit 2024
-
January 9, 2024 | San Francisco, CaliforniaBass, Berry & Sims
Media Mentions & Firm News
-
November 21, 2024 | Firm News
-
September 23, 2024 | Pharmacy Practice News
-
September 9, 2024 | AIS Health
Additional News & Insights
Publication
- Co-author – “HHS Issues Guidance on Permitted Remuneration for Prescription Refill Reminders in the Absence of Patient Authorization,” Health Lawyers Weekly (October 11, 2013)
Presentation
- “What You Don’t Know Can Hurt You: The Top 10 Things You Need to Know About Health Law for Your Practice,” Memphis Bar Association Bench Bar & Boardroom Conference (May 2014)
Publications
-
December 10, 2024 | Firm Publication
-
August 8, 2024 | Firm Publication
-
July 15, 2024 | Firm Publication
-
June 27, 2024 | Firm Publication
-
May 23, 2024 | Firm Publication
-
May 14, 2024 | Firm Publication
-
April 26, 2024 | Firm Publication
-
February 5, 2024 | Firm Publication, AIS Health, Drug Channels
-
January 25, 2024 | Firm Publication
-
January 17, 2024 | Firm Publication
-
January 11, 2024 | Firm Publication
-
January 8, 2024 | Firm Publication
-
November 8, 2023 | Firm Publication
-
November 6, 2023 | Firm Publication
-
September 20, 2023 | Firm Publication
-
August 30, 2023 | Firm Publication
-
August 9, 2023 | Firm Publication
-
July 13, 2023 | Law360
-
May 11, 2023 | Firm Publication
-
April 20, 2023 | Fierce Healthcare
-
March 28, 2023 | MedCity News
-
March 14, 2023 | Firm Publication
-
March 9, 2023 | Firm Publication
-
February 16, 2023 | Firm Publication
-
February 2, 2023 | Firm Publication
-
August 12, 2022 | Firm Publication
-
June 16, 2022 | Firm Publication
-
May 25, 2022 | Firm Publication
-
December 15, 2021 | Inside the FCA Blog
-
September 14, 2021 | Firm Publication
-
July 14, 2021 | Firm Publication
-
June 21, 2021 | Firm Publication
-
April 7, 2021 | Firm Publication
-
December 21, 2020 | Firm Publication
-
November 24, 2020 | Firm Publication
-
October 28, 2020 | Firm Publication
-
October 20, 2020 | Firm Publication
-
June 3, 2020 | Firm Publication
-
March 20, 2020 | Firm Publication
-
March 19, 2020 | Firm Publication
-
January 8, 2020 | Pharmaceutical Executive
-
February 4, 2019 | Firm Publication
-
January 22, 2019 | Specialty Pharmacy Times
-
December 21, 2018 | Firm Publication
-
November 29, 2018 | AHLA Connections - November 2018
-
December 6, 2016 | Specialty Pharmacy Times
-
February 8, 2016 | Specialty Pharmacy Times
-
June 1, 2016 | Specialty Pharmacy Times
-
July 24, 2017 | Specialty Pharmacy Times
-
HHS Guidance Requires Specialty Pharmacies to Scrutinize Patient Cost-Sharing and Incentive ProgramsFebruary 13, 2017 | Specialty Pharmacy Times
-
May 11, 2017 | Specialty Pharmacy Times
-
September 15, 2017 | Specialty Pharmacy Times
-
February 15, 2017 | Firm Publication
-
January 3, 2017 | Specialty Pharmacy Times
-
October 24, 2016 | Specialty Pharmacy Times
-
April 29, 2016 | Specialty Pharmacy Times
-
March 28, 2016 | Firm Publication
-
February 24, 2016 | Specialty Pharmacy Times
-
February 3, 2016 | AHLA Life Sciences and Regulation, Accreditation, & Payment Practice Groups Alert
-
January 20, 2016 | Firm Publication
-
January 7, 2016 | Specialty Pharmacy Times
-
November 23, 2015
-
October 8, 2015
-
August 24, 2015
-
August 19, 2015
-
June 25, 2015
-
April 22, 2015
-
April 15, 2015
-
February 26, 2015
-
December 16, 2014
-
December 4, 2014
Media Mentions & Firm News
-
November 21, 2024 | Firm News
-
September 23, 2024 | Pharmacy Practice News
-
September 9, 2024 | AIS Health
-
May 7, 2024 | Memphis Bar Foundation
-
November 29, 2023 | The M&A Advisor, PitchBook
-
October 17, 2022 | WeInfuse Podcast
-
December 11, 2020 | Mid-South Super Lawyers
-
February 6, 2020 | Leadership Council on Legal Diversity
-
November 5, 2019 | Mid-South Super Lawyers
-
January 10, 2019 | Personnel Announcement
-
November 9, 2018 | Mid-South Super Lawyers
-
March 5, 2018 | Attorney Spotlight
-
November 7, 2017
-
November 8, 2016
-
February 15, 2016 | Specialty Pharmacy Times
-
November 9, 2015
-
February 16, 2015
-
November 5, 2014
-
August 11, 2014
Accolades
Leadership Council on Legal Diversity (LCLD) — Fellow (2020)
Mid-South Super Lawyers (2024); “Rising Star” (2013-2020)
Cecil C. Humphreys Law Review
Accolades
Leadership Council on Legal Diversity (LCLD) — Fellow (2020)
Mid-South Super Lawyers (2024); “Rising Star” (2013-2020)
Cecil C. Humphreys Law Review
Related Services
Related Industries
-
University of Memphis Cecil C. Humphreys School of Law - J.D., 2010
summa cum laude
-
University of Memphis - B.A., 2007
summa cum laude
Education
-
University of Memphis Cecil C. Humphreys School of Law - J.D., 2010
summa cum laude
-
University of Memphis - B.A., 2007
summa cum laude
-
Tennessee, 2010
-
Mississippi, 2010
-
U.S. Court of Appeals, Sixth Circuit, 2012
-
U.S. District Court, Southern District of Mississippi, 2011
-
U.S. District Court, Northern District of Mississippi, 2010
-
U.S. District Court, Western District of Tennessee, 2010
-
Mississippi Supreme Court, 2010
Admissions
-
Tennessee, 2010
-
Mississippi, 2010
-
U.S. Court of Appeals, Sixth Circuit, 2012
-
U.S. District Court, Southern District of Mississippi, 2011
-
U.S. District Court, Northern District of Mississippi, 2010
-
U.S. District Court, Western District of Tennessee, 2010
-
Mississippi Supreme Court, 2010